A Day Up For Virpax Pharmaceuticals Inc.
Tue, Jul 16, 2024 at 07:16 PM
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ) shot up at $1.51, a gain of 41.1%. On Tue, Jul 16, 2024, VRPX:NASDAQ hit a New 2-Week Intraday High of $1.74. The stock appeared on our News Catalysts scanner on Wed, Jul 10, 2024 at 11:53 AM in the 'MISCELLANEOUS' category. From Tue, Jul 02, 2024, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Wed, Jul 10, 2024 at $3.39 with a volume of 117M+.
About Virpax Pharmaceuticals Inc. (VRPX:NASDAQ)
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
Top 10 Gainers:
- Yoshitsu Co. Ltd (TKLF:NASDAQ), 103.4%
- Logistic Properties of the Americas (LPA:NYSEMKT), 69.38%
- Naas Technology Inc. (NAAS:NASDAQ), 66.43%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Locafy Limited (LCFY:NASDAQ), 49.32%
- Alpha Technology Group Limited (ATGL:NASDAQ), 45.64%
- Linkage Global Inc (LGCB:NASDAQ), 44.13%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 41.12%
- Pacific Biosciences of California, Inc. (PACB:NASDAQ), 34.26%
- New Horizon Aircraft Ltd. (HOVR:NASDAQ), 32.22%